Clinical Trials Directory

Trials / Unknown

UnknownNCT03655288

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
IlDong Pharmaceutical Co Ltd · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Post-marketing surveillance of Twotopsplus.

Detailed description

This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.

Conditions

Timeline

Start date
2017-07-25
Primary completion
2023-05-01
Completion
2023-11-01
First posted
2018-08-31
Last updated
2018-09-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03655288. Inclusion in this directory is not an endorsement.

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus. (NCT03655288) · Clinical Trials Directory